Max Rady College of Medicine

Term: Use of Infertility Drugs Prior to a Live Birth

Printer friendly

Glossary Definition

Last Updated: 2012-11-05


This indicator identifies the number of women, aged 18-44, having a live birth following the use of any drug (see list below) for ovulation induction or controlled ovarian hyperstimulation in the two years prior to giving birth. The indicator was calculated by dividing this number by the total number of women giving birth in a given place and time.

The DINS (Drug Identification Numbers) of the medications used to identify ovulation induction or controlled ovarian hyperstimulation are: 00254916 , 00368385, 00640158, 00755613, 00893722, 01925679, 01958992, 02041820, 02042096, 02091879, 02125405, 02125412, 02182904, 02231464, 02231465, 02231655, 02242439, 02242441 , 02243004, 02243948, 02244787, 02247459, 02247790, 02248154, 02248156, 02248157, 02262088, 02268140, 02269066, 02270382, 02270390, 02270404, 02283093, and 02344815. Leterzole (less than 15 pills per month): 02231384, 02348969, 02347997, 02338459, 02322315 was also included.

Related concepts 

Related terms 


  • Heaman M, Kingston D, Helewa M, Brownell M, Derksen S, Bogdanovic B, McGowan K, Bailly A. Perinatal Services and Outcomes in Manitoba. Winnipeg, MB: Manitoba Centre for Health Policy, 2012. [Report] [Summary] [Updates and Errata] (View)

Request information in an accessible format

If you require access to our resources in a different format, please contact us:

We strive to provide accommodations upon request in a reasonable timeframe.

Contact us

Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine,
Rady Faculty of Health Sciences,
Room 408-727 McDermot Ave.
University of Manitoba
Winnipeg, MB R3E 3P5 Canada